PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.

Launched by KIRBY INSTITUTE · Jan 14, 2024

Keywords

ClinConnect Summary

The PATH Study is a clinical trial aimed at understanding the experiences and treatment outcomes of individuals who inject drugs and are hospitalized due to serious infections. These infections can be caused by bacteria or fungi and may affect various parts of the body, including the bloodstream, bones, joints, and skin. The goal of this study is to improve how these patients are treated in the hospital, ensuring they complete their therapy and stay in the hospital for the necessary amount of time to recover. This research will help develop better strategies for both patients and healthcare services.

To be eligible for the study, participants must be 18 years or older, have injected drugs in the past six months, and have been admitted to the hospital with a serious infection. They will need to voluntarily agree to take part in the study by signing a consent form. While the study is not yet recruiting participants, it is an important step toward improving care for individuals facing significant health challenges related to drug use. Participants can expect to share their experiences and contribute to research that aims to enhance treatment outcomes for themselves and others like them.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Have voluntarily signed the informed consent form,
• • 2. 18 years of age or older,
• • 3. Injected drugs within the last 6 months,
• • 4. Admitted to hospital with invasive bacterial or fungal infection, a. Examples of invasive infection include: bloodstream infection, bone and joint infection (osteomyelitis, septic arthritis, discitis), central nervous system infection (epidural abscess, meningitis), deep abscess (i.e., brain, liver, muscle, spleen), endovascular infection (infective endocarditis, septic thrombophlebitis, mycotic aneurysm, septic embolism), skin or soft tissue infection (necrotising fasciitis, myositis),
• Exclusion Criteria:
• • 1) Is unable or unwilling to provide informed consent or abide by the requirements of the study.